Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells

Clinical Cancer Research

Volumn 12, Issue 2, 2006, Pages 608-616

  Liu, Mingjun ^a   Ge, Yubin ^a   Payton, Scott G ^a   Aboukameel, Amro ^a   Buck, Stephen ^b   Flatley, Robin M ^a   Haska, Christina ^a   Mohammad, Ramzi ^a   Taub, Jeffrey W ^a,b   Matherly, Larry H ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; FOLIC ACID DERIVATIVE; IKAROS TRANSCRIPTION FACTOR; METHOTREXATE; REDUCED FOLATE CARRIER; REDUCED FOLATE CARRIER A1; REDUCED FOLATE CARRIER A2; REDUCED FOLATE CARRIER B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILDHOOD LEUKEMIA; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EXON; FEMALE; FOLATE METABOLISM; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; HRFC GENE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT;

ANIMALS; BASE SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXONS; FEMALE; FOLIC ACID; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; IKAROS TRANSCRIPTION FACTOR; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UPSTREAM STIMULATORY FACTORS;

EID: 31544477473     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1954     Document Type: Article

References (32)

1. Margolin JF, Poplack DG. Acute lymphoblastic leukemia. In: Pizza PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: J.B. Lippincott Co.; 1997.
2. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-15.
3. Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR. Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 1996;335:1041-8.
4. Matherly LH, Taub JW. Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia. Leuk Lymphoma 1999;35:1-20.
5. Kager L, Cheok M, Yang W, et al. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 2005;115:110-7.
6. Matherly LH, Goldman ID. Membrane transport of folates. Vitam Horm 2003;66:403-56.
7. Goldman ID, Matherly LH. The cellular pharmacology of methotrexate. Pharmacol Ther 1985;28:77-100.
8. Zhang L, Taub JW, Williamson M, et al. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin Cancer Res 1998;4:2169-77.
9. Rots MG, Willey JC, Van Zantwijk CH, et al. mRNA expression levels of methotrexate resistance related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia 2000;14:2166-75.
10. Flatley RM, Payton SG, Taub JW, Matherly LH. Primary acute lymphoblastic leukemia cells use a novel promoter and 5′ non-coding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start. Clin Cancer Res 2004;10:5111-22.
11. Whetstine JR, Flatley RM, Matherly LH. The human reduced folate carrier gene is ubiquitously and differently expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J 2002;367:629-40.
12. Liu M, Whetstine JR, Payton SG, Ge Y, Flatley RM, Matherly LH. Roles of USF, Ikaros, and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter. Biochem J 2004;383:249-57.
13. Payton SG, Liu M, Ge Y, Matherly LH. Transcriptional regulation of the human reduced folate carrier A1/A2 promoter: identification of critical roles for the USF and GATA families of transcription factors. Biochim Biophys Acta 2005;1731:115-24.
14. Worm J, Kirkin AF, Dzhandzhugazyan KN, Guldberg P. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate- resistant human breast cancer cells. J Biol Chem 2001;276:39990-40000.
15. Ferreri AJ, Dell'Oro S, Capello D, et al. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. Br J Haematol 2004;126:657-64.
16. Payton SG, Whetstine JR, Ge Y, Matherly LH. Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and E/EBP β and identification of a downstream repressor. Biochim Biophys Acta 2005;1727:45-7.
17. Ausuble FM, Brent R, Kingston RE, et al. Current protocols in molecular biology. Vol. 12. New York: John Wiley & Sons Inc; 1998. p. 1.1 -12.1.9.
18. Whetstine JR, Matherly LH. The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a CRE/AP1-like element: basis for tissue specific gene expression. J Biol Chem 2001;276:6350-8.
19. Rein T, Zorbas H, DePamphilis ML. Active mammalian replication origins are associated with a high-density cluster of mCpG dinucleotides. Mol Cell Biol 1997;17:416-26.
20. Zhang L, Wong SC, Matherly LH. Structure and organization of the human reduced folate carrier gene. Biochim Biophys Acta 1998;1442:389-93.
21. Borgmann A, Baldy C, Stackelbert AV, et al. Childhood ALL blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice. Pediatr Hematol Oncol 2000;17:635-50.
22. Nijmeijer BA, Mollevanger P, van Zelderen-Bhola SL, Kluin-Nelemans HC, Willemze R, Falkenburg JHF. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice. Exp Hematol 2001;29:322-9.
23. Molnar A, Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 1994;14:8292-303.
24. Sun L, Liu A, Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996;15:5358-69.
25. Rothem L, Stark M, Kaufman Y, Mayo L, Assaraf YG. Reduced folate carrier gene silencing in multiple antifolate-resistant tumor cell lines is due to a simultaneous loss of function of multiple transcription factors but not promoter methylation. J Biol Chem 2003;279:374-84.
26. Whetstine JR, Witt TL, Matherly LH. The human reduced folate carrier gene is regulated by the AP2 and Sp1 transcription factor families and a 61 base pair polymorphism. J Biol Chem 2002;277:43873-80.
27. Sun L, Crotty ML, Sensel M, et al. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 1999;5:2112-20.
28. Sun L, Goodman PA, Wood CM, et al. Expression of aberrantly 35 spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia. J Clin Oncol 1999;17:3753-66.
29. Sun L, Heerema N, Crotty L, et al. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 1999;96:680-5.
30. Ishimaru F. Expression of Ikaros isoforms in acute lymphoblastic leukemia cell lines. J Clin Oncol 2000;18:1395-7.
31. Whetstine JR, Gifford AJ, Witt T, et al. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high frequency G/A variant at position 80 and transport properties of the His-27 and Arg-27 carriers. Clin Cancer Res 2001;7:3416-22.
32. Matherly LH, Taub JW, Wong SC, et al. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Blood 1997;90:578-89.